{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T13:46:17Z","timestamp":1761918377132},"reference-count":9,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2001,12,20]],"date-time":"2001-12-20T00:00:00Z","timestamp":1008806400000},"content-version":"vor","delay-in-days":294,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2001,3]]},"abstract":"<jats:p>Campath\u20101H, an anti\u2010CD52 monoclonal antibody, is therapeutically active in lymphoproliferative and autoimmune diseases. After Campath\u20101H therapy, lymphocytes with a paroxysmal nocturnal haemoglobinuria (PNH) phenotype have been reported to emerge. We characterized a PNH\u2010like lymphocyte population emerging after Campath\u20101H therapy, in a patient with fludarabine refractory B\u2010cell chronic lymphocytic leukaemia (B\u2010CLL). We demonstrated a reduction in PIG\u2010A mRNA levels compared with controls, and of all cytokines tested [interleukin (IL)\u20104, IL\u201013, IL\u20102, interferon(IFN)\u2010\u03b3, IL\u20106, IL\u201010, and tumour necrosis factor (TNF)\u2010\u03b1], except transforming growth factor (TGF)\u2010\u03b2. Given the inhibitory activity of TGF\u2010\u03b2, its elevated levels may contribute to the selective pressure of Campath\u20101H, leading to the emergence of PNH\u2010like lymphocytes.<\/jats:p>","DOI":"10.1046\/j.1365-2141.2001.02677.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:32:45Z","timestamp":1047364365000},"page":"969-971","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Biological and molecular characterization of PNH\u2010like lymphocytes emerging after Campath\u20101H therapy"],"prefix":"10.1111","volume":"112","author":[{"given":"Nicola S.","family":"Fracchiolla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilma","family":"Barcellini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Motta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Fermo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agostino","family":"Cortelezzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,20]]},"reference":[{"key":"e_1_2_3_2_1","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/8.3.325"},{"key":"e_1_2_3_3_1","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1182\/blood.V86.4.1487.bloodjournal8641487","article-title":"Emergence of CD52\u2010, phosphatidylinositolglycan\u2010anchor\u2010deficient T lymphocytes after in vivo application of Campath\u20101H for refractory B\u2010cell non\u2010Hodgkin lymphoma","volume":"86","author":"Hertenstein B.","year":"1995","journal-title":"Blood"},{"key":"e_1_2_3_4_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1999.00944.x"},{"key":"e_1_2_3_5_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.00595.x"},{"key":"e_1_2_3_6_1","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1182\/blood.V82.8.2379.2379","article-title":"Excessive production of transforming growth factor\u2010beta by bone marrow stromal cells in B\u2010cell chronic lymphocytic leukemia inhibits growth of hematopoietic precursors and interleukin\u20106 production","volume":"82","author":"Lagneaux L.","year":"1993","journal-title":"Blood"},{"key":"e_1_2_3_7_1","doi-asserted-by":"publisher","DOI":"10.1159\/000040948"},{"key":"e_1_2_3_8_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.1998.00615.x"},{"key":"e_1_2_3_9_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01676.x"},{"key":"e_1_2_3_10_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj3220919"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2001.02677.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2001.02677.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.2001.02677.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T16:07:50Z","timestamp":1695830870000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.2001.02677.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,3]]},"references-count":9,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,3]]}},"alternative-id":["10.1046\/j.1365-2141.2001.02677.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.2001.02677.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,3]]},"assertion":[{"value":"2001-12-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}